Search

To investigate how urological studies using composite endpoints as the primary outcome were cited. In this quality analysis of citations, three randomized clinical trials each investigating oncological and non-oncological urology were selected for citation analysis based on pre-defined criteria. In total, 531 papers citing the selected studies were reviewed; citations were evaluated based on whether they correctly referred to the composite endpoint and if singleton endpoints were defined and/or discussed. Among the citations, 223/531 (42%) referred to the composite endpoint, of which 217/223 (97.3%) correctly cited the composite endpoint. However, only 91/217 (41.9%) defined and/or discussed the singleton endpoints of the composite endpoint. The lack of a validated instrument for citation analysis was a limitation of this study. Meanwhile, the main strength is the large number of individually analyzed citations. The composite endpoints of urological randomized clinical trials are generally cited without referring to the composite endpoint; when cited, the composite endpoints are described correctly. However, in most cases, without defining or discussing the singleton endpoints. [ABSTRACT FROM AUTHOR]

Dear Editor, We read with great interest the paper by Banerjee on 50 years' experience of clean intermittent self-catheterization (CISC) [[1]]. Further technical development has later provided female catheters, foldable catheters, and ready-to-use catheters for travelling purposes [[7]] as well as PVC-free catheters developed to reduce environmental impact [[8]]. Various bladder outlet disorders, underactive detrusor, neurogenic and non-neurogenic incontinence as well as voiding complications after bowel surgery or gynaecological procedures are often managed by CISC for longer or shorter periods of time. [Extracted from the article]